Skip to main content
logo
Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada flag Canada · Delayed Price · Currency is CAD
0.5500
0.00 (0.00%)
Aug 6, 2026, 2:05 PM EST

Thiogenesis Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2934283323-
Market Cap Growth
-31.25%22.03%-17.40%48.30%--
Enterprise Value
2130233021-
Last Close Price
0.550.650.600.750.58-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.2458.668.066.053.77-
P/TBV Ratio
4.2458.668.066.053.77-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
------0.43
Net Debt / Equity Ratio
-1.08-2.81-1.12-1.28-1.04-0.38
Quick Ratio
10.691.367.064.1820.360.18
Current Ratio
10.811.467.144.2320.480.18
Return on Equity (ROE)
-181.53%-371.31%-70.25%-87.95%-159.48%-
Return on Assets (ROA)
-87.22%-159.42%-39.85%-48.08%-38.51%-738.68%
Return on Capital Employed (ROCE)
-97.00%-1287.50%-104.50%-94.10%-33.60%157.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-22.86%-22.04%-11.39%-15.15%-17.41%-
Buyback Yield / Dilution
-15.30%-7.11%-15.93%-54.71%-118.86%-15.56%